Skip all navigation Skip to page navigation

DHHS Home | A-Z Site Map | Divisions | About Us | Contacts | En Español

NC Department of Health and Human Services
North Carolina Public Health: Influenza in North Carolina Home
N.C. Public Health Home


Recommendations, Supplies, and Resources

Influenza Vaccine 2013-2014

  • This season’s trivalent influenza vaccines will contain an A/California/7/2009 (H1N1)-like virus, an H3N2 virus antigenically like the cell-propagated prototype virus A/Victoria/361/2011, and a B/Massachusetts/2/2012-like virus. Quadrivalent vaccines will include an additional vaccine virus, a B/Brisbane/60/2008-like virus.
  • Several new, recently-licensed vaccines are available for the 2013-14 season, and are acceptable alternatives to other licensed vaccines indicated for their respective age groups when otherwise appropriate:
    • A quadrivalent live attenuated influenza vaccine (LAIV4; Flumist® Quadrivalent [MedImmune]) has replaced the trivalent (LAIV3) formulation. FluMist® Quadrivalent is indicated for healthy, nonpregnant persons aged 2 through 49 years;
    • A quadrivalent inactivated influenza vaccine (IIV4; Fluarix® Quadrivalent [GlaxoSmithKline]) is available, in addition to the previous trivalent formulation. Fluarix® Quadrivalent is indicated for persons aged 3 years and older;
    • A quadrivalent inactivated influenza vaccine (IIV4; Fluzone® Quadrivalent [Sanofi Pasteur]) is available in addition to the previous trivalent formulation. Fluzone® Quadrivalent is indicated for persons aged 6 months and older;
    • A trivalent cell culture-based inactivated influenza vaccine (ccIIV3; Flucelvax® [Novartis]) is available and is indicated for persons aged 18 years and older; and
    • A recombinant hemagglutinin (HA) vaccine (RIV3; FluBlok® [Protein Sciences]) is available and is indicated for persons aged 18 through 49 years.

A complete list of influenza vaccines available for the 2013–14 season and their age indications is available on the CDC website. Within approved indications and recommendations, no preferential recommendation is made for any type or brand of licensed influenza vaccine over another.

Vaccination Recommendations

  • The CDC’s Advisory Committee on Immunization Practices (ACIP) published complete recommendations for the prevention and control of influenza with vaccines External link in the September 20, 2013 edition of the Morbidity and Mortality Weekly Report (MMWR).
  • The ACIP recommends annual influenza vaccination for all persons aged ≥ 6 months. 
  • The ACIP recommends all health care workers receive a flu vaccine. Be sure to get your vaccine and encourage your colleagues to do the same.

Use of State-Supplied Influenza Vaccine

Influenza vaccine provided by the North Carolina Immunization Program (NCIP) is only available for children who are eligible for the Vaccines for Children (VFC) program. Providers wishing to immunize adult patients or children who are not VFC-eligible must purchase vaccine for those groups. Refer to the current NCIP coverage criteria and definitions of VFC categories for more information.

Resources for Providers

Resources for Educating Patients

General Public